Heart Failure Device Trial Investigators Search For Metrics Beyond Mortality
This article was originally published in The Gray Sheet
Executive Summary
FDA should collaborate with the Heart Failure Society of America to draft guidelines for composite and surrogate endpoints in heart failure device trials, HFSA workshop participants urged April 1